Regenerative medicine in the retina: from stem cells to cell replacement therapy.

ABSTRACT: Following the fast pace of the growing field of stem cell research, retinal cell replacement is finally emerging as a feasible mean to be explored for clinical application. Although neuroprotective treatments are able to slow the progression of retinal degeneration caused by diseases such as age-related macular degeneration and glaucoma, they are insufficient to fully halt disease progression and unable to recover previously lost vision. Comprehensive, technological and intellectual advances over the past years, including the in vitro differentiation of retinal cells at manufacturing scale from embryonic stem (ES) cell and induced pluripotent stem (iPS) cell cultures, progress within the area of retinal disease modeling, and the first clinical trials have started to shape the way to

SUBMITTER: Oswald J 

PROVIDER: S-EPMC6016968 | biostudies-literature | 2018 Jan-Dec

REPOSITORIES: biostudies-literature